Johnson & Johnson recalls Cilest birth control pills reut.rs/15GlCDD

Boehringer and Lilly launch diabetes game pharmafile.com/news/179519/bo… #gamification

American Society of Clinical Oncology conference:Bayer's Nexavar gets boost,while Roche's Avastin reports mixed:fiercepharma.com/story/asco-bay… #ASCO

EU fines Lundbeck and others 146 million euros for blocking rival drugs reut.rs/19hXxVt

AstraZeneca, BMS Onglyza Diabetes Drug Disappoints in Heart Trial pharmalive.com/astrazeneca-bm…

Roche stops diabetes drug aleglitaza trial after safety issues reut.rs/16pommQ

Is India about to become the next hotbed for original pharma research? newstatesman.com/business/2013/…

6 Marketing Trends to Watch in 2013: New Research socialmediaexaminer.com/marketing-tren…

FDA clarifies import rules for 'pre-launch' medicines - New draft guidance on the import of unapproved medicines: pharmafile.com/news/180314/fd…

Ipsos and Synovate: two years on research-live.com/features/ipsos…

IQWiG, the German NICE, publish a paper showing why we need access to all Clinical Study Reports #alltrials iqwig.de/en/press/furth…

Express Scripts stops covering key Big Pharma drugs on clinical, cost-effectiveness grounds: fiercepharma.com/story/express-…

Top 15 Drug Launch Superstars - FiercePharma: fiercepharma.com/special-report…

Tivicay marks beginning of end in growth of HIV branded market, forecast says: fiercepharma.com/story/tivicay-…

Doctors’ groups are criticised for endorsing pro-industry guidelines bmj.com/content/347/bm…

UK to unveil new scheme to curb drug prices -sources reut.rs/1cCVfpc

Life expectancy 'not reduced' by intensive type 1 #diabetes treatment medicalnewstoday.com/articles/28765…

Top marketers reveal their priorities for 2015, do you have yours sorted? CampaignBrands ow.ly/GZ3Z3

First #Biosimilar from #Biogen & JV partner, Samsung Bioepis, receives EU approval bit.ly/1QekCju

Samsung’s Enbrel biosimilar gains European approval koreaherald.com/view.php?ud=20…